1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MARINUS PHARMACEUTICALS INC

Marinus Pharmaceuticals Inc

XNAS: MRNS

Watchlist

Portfolio

Share


Insider Trading disclosures for Marinus Pharmaceuticals Inc

The latest disclosure was made by Elan Ezickson in Marinus Pharmaceuticals Inc where a trade of 1,600 Common Stock done at an average price of $0.5 was reported to US exchanges on Jan. 21, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Elan Ezickson Director Sale of securities on an exchange or to another person at price $ 0.54 per share. 21 Jan 2025 1,600 10,900 (0%) 0% 0.5 864 Common Stock
Marvin H. Johnson Director Sale of securities on an exchange or to another person at price $ 0.54 per share. 21 Jan 2025 1,610 12,490 (0%) 0% 0.5 869 Common Stock
Mayleben Timothy M. Director Gift of securities by or to the insider at price $ 0.00 per share. 10 Oct 2024 1,660 10,637 (0%) 0% 0 Common Stock
Mayleben Timothy M. Director Gift of securities by or to the insider at price $ 0.00 per share. 10 Oct 2024 1,660 12,297 (0%) 0% 0 Common Stock
Mayleben Timothy M. Director Gift of securities by or to the insider at price $ 0.00 per share. 10 Oct 2024 4,980 13,957 (0%) 0% 0 Common Stock
Martha E. Manning SVP, GEN. COUNSEL & CORP. SEC. Sale of securities on an exchange or to another person at price $ 1.13 per share. 05 Aug 2024 3,621 60,263 (0%) 0% 1.1 4,092 Common Stock
Scott Braunstein Director, CHAIRMAN AND CEO Sale of securities on an exchange or to another person at price $ 1.13 per share. 05 Aug 2024 12,145 298,667 (0%) 0% 1.1 13,724 Common Stock
Joseph Hulihan CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 1.13 per share. 05 Aug 2024 4,828 72,725 (0%) 0% 1.1 5,456 Common Stock
Steven Pfanstiel CFO AND COO Sale of securities on an exchange or to another person at price $ 1.13 per share. 05 Aug 2024 4,657 79,773 (0%) 0% 1.1 5,262 Common Stock
Christina Shafer CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 1.14 per share. 05 Aug 2024 3,820 67,406 (0%) 0% 1.1 4,355 Common Stock
Martha E. Manning SVP, GEN. COUNSEL & CORP. SEC. Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 10,918 63,884 (0%) 0% 0 Common Stock
Martha E. Manning SVP, GEN. COUNSEL & CORP. SEC. Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 49,125 49,125 - - Stock Option (Right to Buy)
Timothy M. Mayleben Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 2,300 24,375 (0%) 0% 0 Common Stock
Timothy M. Mayleben Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 10,450 10,450 - - Stock Option (Right to Buy)
Elan Ezickson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 10,450 10,450 - - Stock Option (Right to Buy)
Elan Ezickson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 2,300 12,500 (0%) 0% 0 Common Stock
Seth H.Z. Fischer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 2,300 12,926 (0%) 0% 0 Common Stock
Seth H.Z. Fischer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 10,450 10,450 - - Stock Option (Right to Buy)
Scott Braunstein Director, CHAIRMAN AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 37,300 310,812 (0%) 0% 0 Common Stock
Scott Braunstein Director, CHAIRMAN AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 167,825 167,825 - - Stock Option (Right to Buy)
Sarah B. Noonberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 10,450 10,450 - - Stock Option (Right to Buy)
Sarah B. Noonberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 2,300 14,100 (0%) 0% 0 Common Stock
Christine Berni Silverstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 2,300 14,100 (0%) 0% 0 Common Stock
Christine Berni Silverstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 10,450 10,450 - - Stock Option (Right to Buy)
Joseph Hulihan CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 49,125 49,125 - - Stock Option (Right to Buy)
Joseph Hulihan CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 10,918 77,553 (0%) 0% 0 Common Stock
Charles Austin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 2,300 12,177 (0%) 0% 0 Common Stock
Charles Austin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 10,450 10,450 - - Stock Option (Right to Buy)
Marvin H. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 2,300 14,100 (0%) 0% 0 Common Stock
Marvin H. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 10,450 10,450 - - Stock Option (Right to Buy)
Saraswathy V. Nochur Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 10,450 10,450 - - Stock Option (Right to Buy)
Saraswathy V. Nochur Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 2,300 13,250 (0%) 0% 0 Common Stock
Steven Pfanstiel CFO AND COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 12,733 84,430 (0%) 0% 0 Common Stock
Steven Pfanstiel CFO AND COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 57,300 57,300 - - Stock Option (Right to Buy)
Christina Shafer CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 49,125 49,125 - - Stock Option (Right to Buy)
Christina Shafer CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 10,918 71,226 (0%) 0% 0 Common Stock
Scott Braunstein Director, CHAIRMAN AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Mar 2024 50,000 200,000 - - Stock Option (Right to Buy)
Scott Braunstein Director, CHAIRMAN AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.28 per share. 27 Mar 2024 50,000 273,512 (0%) 0% 4.3 214,000 Common Stock
E. Martha Manning SVP, GEN. COUNSEL & CORP. SEC. Sale of securities on an exchange or to another person at price $ 9.57 per share. 20 Feb 2024 1,894 52,966 (0%) 0% 9.6 18,126 Common Stock
Shafer Christina CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 9.56 per share. 20 Feb 2024 2,153 60,308 (0%) 0% 9.6 20,583 Common Stock
Hulihan Joseph CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 9.98 per share. 16 Feb 2024 2,814 66,635 (0%) 0% 10.0 28,084 Common Stock
Steven Pfanstiel CFO AND COO Sale of securities on an exchange or to another person at price $ 9.97 per share. 16 Feb 2024 3,092 71,697 (0%) 0% 10.0 30,827 Common Stock
Braunstein Scott Director, CHAIRMAN AND CEO Sale of securities on an exchange or to another person at price $ 9.94 per share. 16 Feb 2024 11,850 223,512 (0%) 0% 9.9 117,789 Common Stock
Pfanstiel Steven CFO AND COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 25,465 74,789 (0%) 0% 0 Common Stock
Charles Austin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 4,600 9,877 (0%) 0% 0 Common Stock
Austin Charles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 20,900 20,900 - - Stock Option (Right to Buy)
Scott Braunstein Director, CHAIRMAN AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 335,650 335,650 - - Stock Option (Right to Buy)
Steven Pfanstiel CFO AND COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 114,600 114,600 - - Stock Option (Right to Buy)
Elan Ezickson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 4,600 10,200 (0%) 0% 0 Common Stock
Elan Ezickson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 20,900 20,900 - - Stock Option (Right to Buy)
Joseph Hulihan CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 21,835 69,449 (0%) 0% 0 Common Stock
Christine Berni Silverstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 20,900 20,900 - - Stock Option (Right to Buy)
Christina Shafer CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 21,835 62,461 (0%) 0% 0 Common Stock
Johnson Marvin H. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 20,900 20,900 - - Stock Option (Right to Buy)
Nochur V. Saraswathy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 4,600 10,950 (0%) 0% 0 Common Stock
Martha E. Manning SVP, GEN. COUNSEL & CORP. SEC. Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 21,835 54,860 (0%) 0% 0 Common Stock
Sarah Noonberg B. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 20,900 20,900 - - Stock Option (Right to Buy)
Seth Fischer H.Z. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 4,600 10,626 (0%) 0% 0 Common Stock
Nochur V. Saraswathy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 20,900 20,900 - - Stock Option (Right to Buy)
Sarah B. Noonberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 4,600 11,800 (0%) 0% 0 Common Stock
H. Johnson Marvin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 4,600 11,800 (0%) 0% 0 Common Stock
Mayleben M. Timothy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 4,600 22,075 (0%) 0% 0 Common Stock
H.Z. Fischer Seth Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 20,900 20,900 - - Stock Option (Right to Buy)
Scott Braunstein Director, CHAIRMAN AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 74,600 235,362 (0%) 0% 0 Common Stock
Shafer Christina CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 98,250 98,250 - - Stock Option (Right to Buy)
Manning Martha E. SVP, GEN. COUNSEL & CORP. SEC. Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 98,250 98,250 - - Stock Option (Right to Buy)
Hulihan Joseph CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 98,250 98,250 - - Stock Option (Right to Buy)
Mayleben Timothy M. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 20,900 20,900 - - Stock Option (Right to Buy)
Christine Silverstein Berni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 4,600 11,800 (0%) 0% 0 Common Stock
Martha E. Manning SVP, GEN. COUNSEL & CORP. SEC. Sale of securities on an exchange or to another person at price $ 8.91 per share. 07 Aug 2023 11 33,025 (0%) 0% 8.9 98 Common Stock
Martha E. Manning SVP, GEN. COUNSEL & CORP. SEC. Sale of securities on an exchange or to another person at price $ 9.54 per share. 07 Aug 2023 2,169 33,036 (0%) 0% 9.5 20,692 Common Stock
Scott Braunstein Director, CHAIRMAN AND CEO Sale of securities on an exchange or to another person at price $ 8.93 per share. 07 Aug 2023 30 160,762 (0%) 0% 8.9 268 Common Stock
Scott Braunstein Director, CHAIRMAN AND CEO Sale of securities on an exchange or to another person at price $ 9.55 per share. 07 Aug 2023 6,413 160,792 (0%) 0% 9.5 61,244 Common Stock
Joseph Hulihan CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 9.55 per share. 07 Aug 2023 2,889 47,627 (0%) 0% 9.6 27,590 Common Stock
Joseph Hulihan CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 8.92 per share. 07 Aug 2023 13 47,614 (0%) 0% 8.9 116 Common Stock
Steven Pfanstiel CFO AND COO Sale of securities on an exchange or to another person at price $ 8.93 per share. 07 Aug 2023 14 49,324 (0%) 0% 8.9 125 Common Stock
Steven Pfanstiel CFO AND COO Sale of securities on an exchange or to another person at price $ 9.54 per share. 07 Aug 2023 2,790 49,338 (0%) 0% 9.5 26,617 Common Stock
Christina Shafer CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 8.91 per share. 07 Aug 2023 11 40,626 (0%) 0% 8.9 98 Common Stock
Christina Shafer CHIEF COMMERCIAL OFFICER Sale of securities on an exchange or to another person at price $ 9.52 per share. 07 Aug 2023 2,385 40,637 (0%) 0% 9.5 22,705 Common Stock
Sarah B. Noonberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2023 7,200 7,200 (0%) 0% 0 Common Stock
Sarah B. Noonberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2023 32,400 32,400 - - Stock Option (Right to Buy)
Marvin H. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2023 32,400 32,400 - - Stock Option (Right to Buy)
Marvin H. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2023 7,200 7,200 (0%) 0% 0 Common Stock
Elan Ezickson Director Sale of securities on an exchange or to another person at price $ 6.56 per share. 06 Feb 2023 750 5,600 (0%) 0% 6.6 4,920 Common Stock
Seth H.Z. Fischer Director Sale of securities on an exchange or to another person at price $ 6.54 per share. 06 Feb 2023 1,018 6,026 (0%) 0% 6.5 6,658 Common Stock
Charles Austin Director Sale of securities on an exchange or to another person at price $ 6.49 per share. 06 Feb 2023 1,073 5,277 (0%) 0% 6.5 6,964 Common Stock
Martha E. Manning VP, GEN. COUNSEL & CORP. SEC. Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 16,548 35,205 (0%) 0% 0 Common Stock
Martha E. Manning VP, GEN. COUNSEL & CORP. SEC. Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 74,468 74,468 - - Stock Option (Right to Buy)
Timothy M. Mayleben Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 16,200 16,200 - - Stock Option (Right to Buy)
Timothy M. Mayleben Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 3,600 17,475 (0%) 0% 0 Common Stock
Elan Ezickson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 16,200 16,200 - - Stock Option (Right to Buy)
Elan Ezickson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 3,600 6,350 (0%) 0% 0 Common Stock
Seth H.Z. Fischer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 3,600 7,044 (0%) 0% 0 Common Stock
Seth H.Z. Fischer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 16,200 16,200 - - Stock Option (Right to Buy)
Scott Braunstein Director, CHAIRMAN AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 80,000 167,205 (0%) 0% 0 Common Stock
Scott Braunstein Director, CHAIRMAN AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 360,000 360,000 - - Stock Option (Right to Buy)
Christine Berni Silverstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 7,200 7,200 (0%) 0% 0 Common Stock
Christine Berni Silverstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 32,400 32,400 - - Stock Option (Right to Buy)
Joseph Hulihan CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 115,418 115,418 - - Stock Option (Right to Buy)
Joseph Hulihan CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 25,648 50,516 (0%) 0% 0 Common Stock
Charles Austin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 3,600 6,350 (0%) 0% 0 Common Stock
Charles Austin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 16,200 16,200 - - Stock Option (Right to Buy)
Saraswathy V. Nochur Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 16,200 16,200 - - Stock Option (Right to Buy)
Saraswathy V. Nochur Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 3,600 6,350 (0%) 0% 0 Common Stock
Steven Pfanstiel CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 126,585 126,585 - - Stock Option (Right to Buy)
Steven Pfanstiel CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 28,130 52,128 (0%) 0% 0 Common Stock
Christina Shafer CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 78,188 78,188 - - Stock Option (Right to Buy)
Christina Shafer CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 17,375 43,022 (0%) 0% 0 Common Stock
Christina Shafer Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.70 per share. 09 Nov 2022 1,505 25,647 (0%) 0% 4.7 7,074 Common Stock
Martha E. Manning VP Gen Counsel and Corp Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 5,790 18,657 (0%) 0% 0 Common Stock
Scott Braunstein Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 19,305 87,205 (0%) 0% 0 Common Stock
Joseph Hulihan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 7,718 24,868 (0%) 0% 0 Common Stock
Steven Pfanstiel Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 7,448 23,998 (0%) 0% 0 Common Stock
Martha E. Manning VP Gen Counsel and Corp Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 12,867 12,867 (0%) 0% 0 Common Stock
Martha E. Manning VP Gen Counsel and Corp Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 57,900 57,900 - - Stock Option (Right to Buy)
Timothy M. Mayleben Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 2,750 13,875 (0%) 0% 0 Common Stock
Timothy M. Mayleben Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 12,375 12,375 - - Stock Option (Right to Buy)
Nicole Vitullo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 12,375 12,375 - - Stock Option (Right to Buy)
Nicole Vitullo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 2,750 6,442 (0%) 0% 0 Common Stock
Michael R. Dougherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 12,375 12,375 - - Stock Option (Right to Buy)
Michael R. Dougherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 2,750 3,312 (0%) 0% 0 Common Stock
Elan Ezickson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 12,375 12,375 - - Stock Option (Right to Buy)
Elan Ezickson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 2,750 2,750 (0%) 0% 0 Common Stock
Seth H.Z. Fischer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 2,750 3,444 (0%) 0% 0 Common Stock
Seth H.Z. Fischer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 12,375 12,375 - - Stock Option (Right to Buy)
Scott Braunstein Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 193,050 193,050 - - Stock Option (Right to Buy)
Scott Braunstein Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 42,900 67,900 (0%) 0% 0 Common Stock
Santiago Arroyo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 12,375 12,375 - - Stock Option (Right to Buy)
Santiago Arroyo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 2,750 2,750 (0%) 0% 0 Common Stock
Joseph Hulihan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 17,150 17,150 (0%) 0% 0 Common Stock
Joseph Hulihan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 77,175 77,175 - - Stock Option (Right to Buy)
Charles Austin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 12,375 12,375 - - Stock Option (Right to Buy)
Charles Austin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 2,750 2,750 (0%) 0% 0 Common Stock
Saraswathy V. Nochur Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 2,750 2,750 (0%) 0% 0 Common Stock
Saraswathy V. Nochur Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 12,375 12,375 - - Stock Option (Right to Buy)
Steven Pfanstiel Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 74,475 74,475 - - Stock Option (Right to Buy)
Steven Pfanstiel Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 16,550 16,550 (0%) 0% 0 Common Stock
Santiago Arroyo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 33,000 33,000 - - Stock option (right to buy)
Steven Pfanstiel CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Apr 2021 220,000 220,000 - - Stock option (right to buy)
Saraswathy V. Nochur Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Mar 2021 33,000 33,000 - - Stock option (right to buy)
Nicole Vitullo Director Other type of transaction at price $ 0.00 per share. 12 Mar 2021 6,192 0 (0%) 0% 0 Common Stock
Nicole Vitullo Director Sale of securities on an exchange or to another person at price $ 15.87 per share. 12 Mar 2021 4,250 0 (0%) 0% 15.9 67,448 Common Stock
Nicole Vitullo Director Other type of transaction at price $ 0.00 per share. 12 Mar 2021 619,221 0 (0%) 0% 0 Common Stock
Nicole Vitullo Director Other type of transaction at price $ 0.00 per share. 12 Mar 2021 6,192 6,192 (0%) 0% 0 Common Stock
Nicole Vitullo Director Other type of transaction at price $ 0.00 per share. 12 Mar 2021 2,717 3,692 (0%) 0% 0 Common Stock
Nicole Vitullo Director Other type of transaction at price $ 0.00 per share. 12 Mar 2021 11,612 0 (0%) 0% 0 Common Stock
Edward F. Smith Former VP, CFO & Treasurer Sale of securities on an exchange or to another person at price $ 17.80 per share. 09 Mar 2021 40,356 13,288 (0%) 0% 17.8 718,337 Common Stock
Edward F. Smith Former VP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.16 per share. 09 Mar 2021 35,927 53,644 (0%) 0% 4.2 149,456 Common Stock
Edward F. Smith Former VP, CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2021 35,927 0 - - Stock Option (right to buy)
Martha E. Manning VP Gen Counsel and Corp Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2021 57,500 57,500 - - Stock option (right to buy)
Timothy M. Mayleben Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2021 16,500 16,500 - - Stock option (right to buy)
Nicole Vitullo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2021 16,500 16,500 - - Stock Option (Right to Buy)
Michael R. Dougherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2021 16,500 16,500 - - Stock option (right to buy)
Elan Ezickson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2021 16,500 16,500 - - Stock option (right to buy)
Enrique J. Carrazana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2021 16,500 16,500 - - Stock option (right to buy)
Seth H.Z. Fischer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2021 16,500 16,500 - - Stock option (right to buy)
Scott Braunstein Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2021 290,000 290,000 - - Stock option (right to buy)
Joseph Hulihan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2021 115,000 115,000 - - Stock option (right to buy)
Charles Austin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2021 16,500 16,500 - - Stock option (right to buy)
Charles Austin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2020 100,000 100,000 - - Stock option (right to buy)
Edward F. Smith CFO Sale of securities on an exchange or to another person at price $ 2.05 per share. 30 Jan 2020 2,380 17,717 (0%) 0% 2.1 4,879 Common stock
Timothy M. Mayleben Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2020 100,000 100,000 - - Stock option (right to buy)
Nicole Vitullo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2020 150,000 150,000 - - Stock Option (Right to Buy)
Michael R. Dougherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2020 100,000 100,000 - - Stock option (right to buy)
Edward F. Smith CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2020 765,000 765,000 - - Stock option (right to buy)
Enrique J. Carrazana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2020 100,000 100,000 - - Stock option (right to buy)
Seth H.Z. Fischer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2020 100,000 100,000 - - Stock option (right to buy)
Scott Braunstein Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2020 1,800,000 1,800,000 - - Stock option (right to buy)
Joseph Hulihan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2020 405,000 405,000 - - Stock option (right to buy)
Scott Braunstein Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.25 per share. 13 Dec 2019 100,000 100,000 (0%) 0% 1.3 125,000 Common stock
Elan Ezickson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2019 100,000 100,000 - - Stock option (right to buy)
Lorianne K. Masuoka Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Aug 2019 60,000 60,000 - - Stock option (right to buy)
Edward F. Smith CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Aug 2019 60,000 60,000 - - Stock option (right to buy)
Scott Braunstein Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Aug 2019 1,000,000 1,000,000 - - Stock option (right to buy)
Edward F. Smith CFO Sale of securities on an exchange or to another person at price $ 5.03 per share. 16 May 2019 24,211 20,097 (0%) 0% 5.0 121,781 Common stock
Christopher M. Cashman Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 18 Mar 2019 31,662 271,423 (0%) 0% 1.0 32,928 Common stock
Christopher M. Cashman Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2019 31,662 0 - - Stock option (right to buy)
Timothy M. Mayleben None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2019 35,000 35,000 - - Stock option (right to buy)
Nicole Vitullo None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2019 35,000 35,000 - - Stock Option (Right to Buy)
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2019 35,000 35,000 - - Stock option (right to buy)
Lorianne K. Masuoka Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2019 200,000 200,000 - - Stock option (right to buy)
Edward F. Smith CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2019 200,000 200,000 - - Stock option (right to buy)
Enrique J. Carrazana None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2019 65,000 65,000 - - Stock option (right to buy)
Seth H.Z. Fischer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2019 35,000 35,000 - - Stock option (right to buy)
Scott Braunstein Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2019 240,000 240,000 - - Stock option (right to buy)
Edward F. Smith CFO Sale of securities on an exchange or to another person at price $ 3.06 per share. 29 Jan 2019 2,492 44,308 (0%) 0% 3.1 7,626 Common stock
Christopher M. Cashman Director, CEO Sale of securities on an exchange or to another person at price $ 3.13 per share. 28 Jan 2019 8,142 239,761 (0%) 0% 3.1 25,484 Common stock
Edward F. Smith CFO Sale of securities on an exchange or to another person at price $ 7.91 per share. 29 Jan 2018 3,000 49,800 (0%) 0% 7.9 23,730 Common stock
Nicole Vitullo None Other type of transaction at price $ 0.00 per share. 22 Jan 2018 2,250 46,450 (0%) 0% 0 Common Stock
Nicole Vitullo None Other type of transaction at price $ 0.00 per share. 22 Jan 2018 2,250 3,900 (0%) 0% 0 Common Stock
Christopher M. Cashman Director, CEO Sale of securities on an exchange or to another person at price $ 6.28 per share. 18 Jan 2018 9,566 247,903 (0%) 0% 6.3 60,074 Common stock
Timothy M. Mayleben None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2017 35,000 35,000 - - Stock option (right to buy)
Nicole Vitullo None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2017 35,000 35,000 - - Stock Option (Right to Buy)
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2017 35,000 35,000 - - Stock option (right to buy)
Lorianne K. Masuoka Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2017 150,000 150,000 - - Stock option (right to buy)
Edward F. Smith CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2017 200,000 200,000 - - Stock option (right to buy)
Enrique J. Carrazana None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2017 35,000 35,000 - - Stock option (right to buy)
Seth H.Z. Fischer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2017 35,000 35,000 - - Stock option (right to buy)
Christopher M. Cashman Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2017 500,000 500,000 - - Stock option (right to buy)
Nicole Vitullo None Other type of transaction at price $ 0.00 per share. 11 Sep 2017 1,650 6,150 (0%) 0% 0 Common Stock
Nicole Vitullo None Other type of transaction at price $ 0.00 per share. 11 Sep 2017 1,650 44,200 (0%) 0% 0 Common Stock
Timothy M. Mayleben None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2017 4,500 50,350 (0%) 0% 0 Common stock
Nicole Vitullo Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2017 10,500 10,500 - - Stock Option (Right to Buy)
Nicole Vitullo Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2017 4,500 7,800 (0%) 0% 0 Common Stock
Jay P. Shepard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2017 10,500 10,500 - - Stock option (right to buy)
Jay P. Shepard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2017 4,500 4,500 - - Restricted stock
Edward F. Smith CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2017 25,200 52,800 (0%) 0% 0 Common stock
Enrique J. Carrazana None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2017 28,500 31,800 (0%) 0% 0 Common stock
Seth H.Z. Fischer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2017 4,500 4,500 - - Restricted stock
Seth H.Z. Fischer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2017 10,500 10,500 - - Stock option (right to buy)
Christopher M. Cashman Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2017 60,600 257,469 (1%) 0% 0 Common stock
Anand Mehra Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Oct 2016 724,788 1,134,851 - - Common Stock
Anand Mehra Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Oct 2016 13,367 224,845 - - Common Stock
Anand Mehra Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Oct 2016 12,528 15,470 - - Common Stock
Jay P. Shepard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 7,700 7,700 - - Stock option (right to buy)
Jay P. Shepard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 3,300 3,300 - - Restricted stock
Nicole Vitullo Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 7,700 7,700 - - Stock Option (Right to Buy)
Nicole Vitullo Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 3,300 3,300 - - Common Stock
Timothy M. Mayleben None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 3,300 45,850 - - Common stock
Edward F. Smith CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 27,600 27,600 - - Common stock
Enrique J. Carrazana None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 3,300 3,300 - - Common stock
Anand Mehra None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 7,700 7,700 - - Stock option (right to buy)
Anand Mehra None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 3,300 3,300 - - Restricted stock
Christopher M. Cashman Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 56,100 196,869 - - Common stock
Albena Patroneva Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 48,300 48,300 - - Stock option (right to buy)
Albena Patroneva Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 20,700 20,700 - - Restricted stock
Enrique J. Carrazana None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2016 25,000 25,000 - - Stock option (right to buy)
Christopher M. Cashman Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Nov 2015 24,684 31,662 - - Employee stock option (right to buy)
Christopher M. Cashman Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Nov 2015 3,561 116,085 - - Common Stock
Christopher M. Cashman Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Nov 2015 24,684 140,769 - - Common Stock
Stephen Bloch None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2015 6,300 6,300 - - Stock option (right to buy)
Stephen Bloch None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Sep 2015 12,515 0 - - Stock option (right to buy)
Stephen Bloch None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Sep 2015 27,035 0 - - Stock option (right to buy)
Stephen Bloch None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Sep 2015 12,515 12,515 - - Common Stock
Stephen Bloch None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Sep 2015 27,035 39,550 - - Common Stock
Jay P. Shepard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2015 6,300 6,300 - - Stock option (right to buy)
Nicole Vitullo Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2015 6,300 6,300 - - Stock Option (Right to Buy)
Timothy M. Mayleben None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2015 6,300 6,300 - - Stock option (right to buy)
Edward F. Smith CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2015 70,000 70,000 - - Stock option (right to buy)
Enrique J. Carrazana None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2015 6,300 6,300 - - Stock option (right to buy)
Anand Mehra Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2015 6,300 6,300 - - Stock option (right to buy)
Christopher M. Cashman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2015 160,000 160,000 - - Stock option (right to buy)
Albena Patroneva Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2015 50,000 50,000 - - Stock option (right to buy)
Timothy M. Mayleben None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jul 2015 15,515 0 - - Stock option (right to buy)
Timothy M. Mayleben None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jul 2015 27,035 0 - - Stock option (right to buy)
Timothy M. Mayleben None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jul 2015 15,515 15,515 - - Common Stock
Timothy M. Mayleben None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jul 2015 27,035 42,550 - - Common Stock
Christopher M. Cashman Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2015 14,086 56,346 - - Employee stock option (right to buy)
Christopher M. Cashman Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2015 14,086 112,524 - - Common Stock
Stephen Bloch None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2015 3,000 12,515 - - Stock option (right to buy)
Stephen Bloch None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2015 3,000 3,000 - - Common Stock
Stephen Bloch None Gift of securities by or to the insider at price $ 0.00 per share. 10 Jun 2015 3,000 0 - - Common Stock
Gail M. Farfel Chief Clinical Dev & Reg Offic Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Apr 2015 30,000 8,462 - - Employee Stock option (right to buy)
Gail M. Farfel Chief Clinical Dev & Reg Offic Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Apr 2015 30,000 30,000 - - Common Stock
Gail M. Farfel Chief Clinical Dev & Reg Offic Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Apr 2015 30,000 0 - - Common Stock
Christopher M. Cashman Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2015 17,608 70,432 - - Employee stock option (right to buy)
Christopher M. Cashman Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2015 17,608 98,438 - - Common Stock
Albena Patroneva Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2014 158,000 158,000 - - Employee stock option (right to buy)
Edward F. Smith CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2014 62,000 62,000 - - Employee stock option (right to buy)
Christopher M. Cashman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2014 275,000 275,000 - - Employee stock option (right to buy)
Gail M. Farfel Chief Clinical Dev & Reg Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2014 43,000 43,000 - - Employee stock option (right to buy)
Christopher M. Cashman Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Oct 2014 80,830 88,040 - - Employee stock option (right to buy)
Christopher M. Cashman Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Oct 2014 80,830 80,830 - - Common Stock
Jay P. Shepard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2014 6,000 6,000 - - Stock option (right to buy)
Nicole Vitullo Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2014 6,000 6,000 - - Stock Option (Right to Buy)
Timothy M. Mayleben None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2014 6,000 6,000 - - Stock option (right to buy)
Stephen Bloch None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2014 6,000 6,000 - - Stock option (right to buy)
Enrique J. Carrazana None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2014 6,000 6,000 - - Stock option (right to buy)
Anton Gopka None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2014 6,000 6,000 - - Stock option (right to buy)
Anand Mehra None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2014 6,000 6,000 - - Stock Option (Right to Buy)
Jesse I. Treu Ten Percent Owner 05 Aug 2014 820,320 0 - - Series A Preferred Stock
Jesse I. Treu Ten Percent Owner 05 Aug 2014 657,192 0 - - Series B Preferred Stock
Jesse I. Treu Ten Percent Owner 05 Aug 2014 579,630 0 - - Series C Preferred Stock
Jesse I. Treu Ten Percent Owner 05 Aug 2014 8,792 0 - - Series A Preferred Stock
Jesse I. Treu Ten Percent Owner 05 Aug 2014 7,043 0 - - Series B Preferred Stock
Jesse I. Treu Ten Percent Owner 05 Aug 2014 1,165 0 - - Series C Preferred Stock
Jesse I. Treu Ten Percent Owner 05 Aug 2014 2,057,142 2,057,142 - - Common Stock
Jesse I. Treu Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Aug 2014 419,744 2,476,886 - - Common Stock
Jesse I. Treu Ten Percent Owner 05 Aug 2014 17,000 17,000 - - Common Stock
Stephen Bloch None 05 Aug 2014 4,742,516 0 - - Series A Preferred Stock
Stephen Bloch None 05 Aug 2014 3,838,214 0 - - Series B Preferred Stock
Stephen Bloch None 05 Aug 2014 3,355,859 0 - - Series C Preferred Stock
Stephen Bloch None Other type of transaction at price $ 0.00 per share. 05 Aug 2014 959,553 0 - - Warrants to Purchase Series B Preferred Stock
Stephen Bloch None 05 Aug 2014 1,836,398 1,836,398 - - Common Stock
Stephen Bloch None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Aug 2014 625,000 2,461,398 - - Common Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 3,212,038 0 - - Series A Preferred Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 636,393 0 - - Series A Preferred Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 43,785 0 - - Series A Preferred Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 2,098,937 0 - - Series B Preferred Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 415,857 0 - - Series B Preferred Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 28,612 0 - - Series B Preferred Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 2,065,553 0 - - Series C Preferred Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 409,241 0 - - Series C Preferred Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 28,156 0 - - Series C Preferred Stock
Anand Mehra Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 05 Aug 2014 524,734 0 - - Preferred Stock Warrant (right to buy)
Anand Mehra Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 05 Aug 2014 103,964 0 - - Preferred Stock Warrant (right to buy)
Anand Mehra Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 05 Aug 2014 7,153 0 - - Preferred Stock Warrant (right to buy)
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 494,161 494,161 - - Common Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 97,907 97,907 - - Common Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 6,736 6,736 - - Common Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 322,913 817,074 - - Common Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 63,978 161,885 - - Common Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 4,402 11,138 - - Common Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 317,777 1,134,851 - - Common Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 62,960 224,845 - - Common Stock
Anand Mehra Director, Ten Percent Owner 05 Aug 2014 4,332 15,470 - - Common Stock
Anand Mehra Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Aug 2014 724,788 1,859,639 - - Common Stock
Anand Mehra Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Aug 2014 13,367 238,212 - - Common Stock
Anand Mehra Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Aug 2014 12,528 27,998 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters